Nation’s First Extracellular Vesicle Clinical Test Program Launched

Taiwan Leads in EV Biomarker Clinical Testing to Improve Early Disease Diagnosis

Latest News
#EV Testing#Biomarker#Clinical Application
In collaboration with several hospitals, our association has launched the nation’s first clinical testing program for extracellular‑vesicle (EV) biomarkers, expected to accelerate early diagnosis and personalized treatment for multiple diseases.

Test items include:
• Early cancer screening
• Neurodegenerative‑disease monitoring
• Chronic‑disease risk assessment

For details, please visit the dedicated section on our website.

Related Articles

Book “Extracellular Vesicles and Regenerative Medicine” Officially Published

Comprehensive Analysis of EV Technologies and Clinical Development Trends

Read More
First Taiwan–Japan Extracellular Vesicle Medical Forum Concludes Successfully

Deepening International Cooperation and Sharing Innovative Applications

Read More
Taiwan Cell and Extracellular Vesicle Industry White Paper Released

Analyzing Current Industry Status and Future Development Blueprint

Read More